Risk factors for level V metastasis in patients with N1b papillary thyroid cancer

被引:0
|
作者
Kang, Jin Gu [1 ]
Choi, Jung Eun [1 ]
Kang, Su Hwan [1 ]
机构
[1] Yeungnam Univ, Dept Surg, Coll Med, 170 Hyunchoong ro, Daegu 42415, South Korea
关键词
Lymph node metastasis; Neck dissection; Thyroid cancer; LYMPH-NODE METASTASIS; LATERAL NECK; PREDICTIVE FACTORS; CARCINOMA; DISSECTION; PATTERN; METAANALYSIS; EXTENT;
D O I
10.1186/s12957-022-02782-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, and its incidence has increased. Lateral lymph node metastasis (LLNM) implies a worse prognosis than central lymph node metastasis, with a higher recurrence rate and decreased disease-free survival. The 2015 American Thyroid Association guidelines recommend compartmental node dissection in patients with LLNM to reduce the risk of recurrence and mortality. The purpose of this study was to identify the risk factors for level V lymph node (LN) metastasis in patients with N1b papillary thyroid cancer (PTC). Methods A total of 110 consecutive patients who underwent total thyroidectomy with lateral neck dissection for PTC between April 2016 and April 2022 were retrospectively enrolled. Based on level V metastasis, 94 patients were divided into two groups, and their clinicopathological characteristics were compared. Univariable analysis were used to assess the factors associated with level V metastasis. Spearman correlation analysis were used to assess the correlation between tumors and LN. The receiver operating characteristic (ROC) curve was used to determine the optimal cutoff value for the number of metastatic LNs at each level for level V metastasis. Results The number of metastatic LNs and lymph node ratio (LNR) in level II were significantly associated with level V metastasis (P = 0.011 and 0.001, respectively). The number of metastatic LNs in level II and those in the total number of levels correlated with the number of metastatic LNs in level V (rho = 0.331, 0.325, and P = 0.001, 0.001, respectively). The cutoff value for the number of metastatic LNs in level II was defined as 2.5 (area under the curve = 0.757, sensitivity = 50%, specificity = 82.5%, 95% confidence interval [CI] 0.626-0.889, P = 0.002). Simultaneous 3-level metastasis (level II, III, and IV) and 3-level with >= 2.5 metastatic LNs in level II were significantly associated with level V metastasis (P = 0.003 and 0.002). Conclusions The number of metastatic LNs and LNR in level II, simultaneous 3-level metastasis (level II, III, and IV), and 3-level with >= 2.5 metastatic LNs in level II were significantly associated with level V metastasis. (P = 0.011, 0.001, 0.003, and 0.002, respectively). In the future, larger-scale multi-institutional studies were needed to find out predictors for level V metastasis.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Risk factors for level V metastasis in patients with N1b papillary thyroid cancer
    Jin Gu Kang
    Jung Eun Choi
    Su Hwan Kang
    World Journal of Surgical Oncology, 20
  • [2] Level V lymph node metastasis in N1b papillary thyroid carcinoma patients: contributing factors and pattern of metastasis
    Yap, Zeng Z.
    Kim, Won W.
    Kang, Sang-Wook
    Lee, Cho R.
    Lee, Jandee
    Jeong, Jong J.
    Nam, Kee-Hyun
    Chung, Woong Y.
    CHIRURGIA-ITALY, 2019, 32 (03): : 128 - 132
  • [3] Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma
    Wu, Yifeng
    Li, Jianjun
    Wu, Xianjiang
    Dai, Lei
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (05) : 559 - 563
  • [4] Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
    Kim, Seo Ki
    Park, Inhye
    Hur, Nayoon
    Lee, Jun Ho
    Choe, Jun-Ho
    Kim, Jung-Han
    Kim, Jee Soo
    THYROID, 2017, 27 (02) : 253 - 260
  • [5] The prognostic factors for clinical N1b patients in thyroid papillary carcinoma
    Yuksel, Ulvi Murat
    Turanli, Sevim
    Acar, Yunus
    Berberoglu, Ugur
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (03) : 681 - 685
  • [6] Management of Lateral Multiple-Level Metastasis in N1b Papillary Thyroid Microcarcinoma
    Wang, Wenlong
    Zhang, Zhejia
    Zhao, Yunzhe
    Xue, Wenbo
    Xia, Fadao
    Li, Xinying
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] Differentiated Thyroid Cancer: The Role ofATANodal Risk Factors in N1b Patients
    Taboni, Stefano
    Paderno, Alberto
    Giordano, Davide
    Albano, Domenico
    Piana, Simonetta
    Zanetti, Eleonora
    Bertagna, Francesco
    Grammatica, Alberto
    Ghidini, Angelo
    Cappelli, Carlo
    Bozzola, Anna
    Baronchelli, Carla
    Nicolai, Piero
    Lombardi, Davide
    LARYNGOSCOPE, 2021, 131 (03): : E1029 - E1034
  • [8] Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma
    Lee, Sang Hun
    Roh, Jong-Lyel
    Gong, Gyungyup
    Cho, Kyung-Ja
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    ANNALS OF SURGERY, 2019, 269 (05) : 966 - 971
  • [9] Patterns, predictive factors and prognostic impact of multilevel metastasis in N1b papillary thyroid carcinoma
    Kim, S. K.
    Park, I.
    Hur, N.
    Choe, J-H.
    Kim, J-H.
    Kim, J. S.
    BRITISH JOURNAL OF SURGERY, 2017, 104 (07) : 857 - 867
  • [10] Feasibility of Lobectomy in Selected Patients with Unilateral N1b Papillary Thyroid Cancer
    Danxia Li
    Guojun Zhang
    Xinna Li
    Shuo Xu
    Haiqing Sun
    Yang Liu
    Guochang Wu
    Haitao Zheng
    Xiaoli Zhang
    Guibin Zheng
    Annals of Surgical Oncology, 2025, 32 (4) : 2344 - 2352